New Lion Capital

McKinsey Investment Office Partners (MIO Partners) is a private investment office for McKinsey alumni. It invests primarily through other funds and also makes direct investments, operating independently of McKinsey & Company.

Point72 is a global alternative investment manager with fundamental-equity, systematic, macro, private-credit and venture-capital strategies; its venture strategy is Point72 Ventures.

Investment firm with public-equity long/short, long-focused and crossover strategies, plus a private-equity business investing in early- through late-stage companies.

Highbridge Capital Management is a global alternative investments firm that invests in a variety of asset classes and strategies. We invest primarily in publicly traded companies

Actis is a leading private equity investor in high growth markets across Africa, Asia and Latin America. We invest in private equity buyouts and grwoth capital, energy, infrastructure and real estate. We have >120 investment professionals across 16 global offices. In every market we invest in, we nurture close local relationships, providing us with excellent competitive intelligence and access to opportunities. We match this local insight with a global sector approach, which helps us deliver great results. A particular strength lies in helping families and founders of local businesses to institutionalise. We take successful local brands and help them to grow; to attract the best talent; to compete with multinational corporations and to prepare for IPOs. Consequently many business founders seek to work with Actis, resulting in unique proprietary deal flow.

Quilvest Private Equity is a generalist private equity firm investing in buyouts and growth-stage opportunities directly and through a fund of funds model, founded in 1972.

Battery Ventures is a technology-focused investment manager making venture-capital and private-equity investments in technology businesses from early stages through growth and buyout.

Wingate is a leading Australian private credit investment manager, specializing in real estate and mid-market corporate debt solutions.

Portland House Group manages the capital of the Australian-based Hains family. Portland House invests in equities (local and global), fixed income, currencies, and asset managers including hedge funds.

Omidyar Network is a philanthropic organization funded directly by Pierre and Pam Omidyar. Its hybrid structure pairs an LLC that invests in startups with a foundation that makes nonprofit grants; its work focuses on technology and the digital future.

Vertex Holdings is a global network of venture capital funds, comprising Vertex Ventures, Vertex Ventures HC and Vertex Growth. Vertex Holdings is an anchor investor in each of these funds. Vertex Holdings is owned by Temasek, a Singapore sovereign wealth fund. Vertex Ventures is based in California and invests in early stage technology companies. Vertex Ventures looks for founders tackling fundamental challenges. We look for people who want to make a dent in the wold while growing a multi-billion dollar business. Vertex HC invests in healthcare opportunities. We invest in and work with high-growth medical device, biotech, and digital health companies, at all stages, worldwide. Our portfolio includes companies at all stages of development, from early-stage companies testing transformative technologies to commercial-stage companies seeking additional growth. The Vertex Growth Fund provides later stage expansion capital to companies on the cusp of creating a category champion that is enduring and transformational.

EPIQ Capital Group is a multi-family office catering to families with a net worth above $100 million. EPIQ does not have its own internal funds or sell any proprietary products of its own, freeing it of potential conflicts of interest. EPIQ was founded by Chad Boeding, who previously co-founded ICONIQ Capital.

Tribeca Investment Partners is an Australian based boutique fund manager with three core funds: Australian small companies, Alpha Plus (long/short Australian equities), and Global Natural Resources (long/short). In addition, Tribeca has a newly raised special situations fund targeting debt and hybrids (including royalties) into resources companies.

Bronte Capital is an Australian-based global long/short fund founded by John Hempton and Simon Maher in 2009. The fund is managed by a performance orientated firm with a process and portfolio that is genuinely different. Objectives include lowering the risk of permanent loss of capital and providing global diversification without the market/drawdown risks typical of long-only funds. Bronte Capital's funds target double digit returns over the long term.

Infrastructure financing vehicle backing government and private projects in Europe, Asia, and Africa, with gold-backed structure and mining investments.

Singtel Innov8 is Singtel Group’s corporate venture capital fund. It invests in companies from seed to early growth and manages an investment fund focused on growth-stage AI companies.

Bioscience Managers is an international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare. Bioscience Managers invests in private and public healthcare companies with clear technological and market advantages in any territory, where we are confident that our engagement with management will deliver commercial success and returns for investors. We are both geographically and therapeutically agnostic. We invest in public and private healthcare companies in any territory which work in therapeutics, medical devices, diagnostics or digital health, which are in or near clinical development or commercialisation. Our strategy is to take a a meaningful stake in our investee companies, including board representation, advisory and or hands-on-roles to augment existing skills and to build a proactive and supportive relationships. We are part of the PhillipCapital Group, which has £30bn under management across 16 offices around the world.